Lessey Bruce A, Young Steven L
Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Greenville Health System, Greenville, South Carolina.
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Semin Reprod Med. 2014 Sep;32(5):365-75. doi: 10.1055/s-0034-1376355. Epub 2014 Jun 24.
Embryo implantation is regulated by an inflammatory process in response to sequential exposure to estrogen and progesterone, followed by resolution and repair. The actions of estrogen and progesterone on these inflammatory processes are tightly and reciprocally controlled through regulated expression of steroid receptors, cofactors, chaperone proteins, and downstream signaling components. In endometriosis, the inflammatory cascades, normally seen at menstruation, are prematurely activated and endogenous endometrial mechanisms of inflammation resolution appear defective. The temporally abnormally inflammation is also associated with an imbalance between estrogen and progesterone actions; the normal luteal-phase dominance of progesterone action appears to be lost and is replaced by progesterone resistance and estrogen dominance. In this review, we examine these relationships in greater detail and argue that estrogen action is a prime target for future therapeutic solutions to endometriosis and implantation failure that result from this chronic, inflammatory disease.
胚胎着床受炎症过程调控,该过程是对依次暴露于雌激素和孕激素后的反应,随后是炎症消退和修复。雌激素和孕激素对这些炎症过程的作用通过类固醇受体、辅因子、伴侣蛋白和下游信号成分的调控表达而受到紧密且相互的控制。在子宫内膜异位症中,通常在月经时出现的炎症级联反应被过早激活,而内源性子宫内膜炎症消退机制似乎存在缺陷。这种时间上异常的炎症还与雌激素和孕激素作用之间的失衡有关;正常情况下孕激素作用在黄体期占主导地位似乎丧失,取而代之的是孕激素抵抗和雌激素占主导。在本综述中,我们更详细地研究了这些关系,并认为雌激素作用是未来治疗因这种慢性炎症性疾病导致的子宫内膜异位症和着床失败的主要治疗靶点。